File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Vacancies-rich Z-scheme VdW heterojunction as H2S-sensitized synergistic therapeutic nanoplatform against refractory biofilm infections

TitleVacancies-rich Z-scheme VdW heterojunction as H2S-sensitized synergistic therapeutic nanoplatform against refractory biofilm infections
Authors
KeywordsAnion vacancy
Biofilm infection
Heterojunction
Synergistic therapy
Wound repair
Issue Date13-Mar-2025
PublisherElsevier
Citation
Biomaterials, 2025, v. 320 How to Cite?
AbstractEncapsulated in a self-produced negatively charged extracellular polymeric substance (EPS) matrix, the wound infected bacterial biofilms exhibit formidable resistance to conventional positively charged antibiotics and host's immune responses, which can undoubtedly lead to persistent infections and lethal complications. Nevertheless, developing efficacious strategies to root out stubborn biofilm and promote tissue regeneration still remains a challenge. To resolve this dilemma, a versatile vacancies-rich Z-scheme MoSSe Van der Waals heterojunction (MoSSe VdW HJ) is rationally fabricated as nanoplatform for hydrogen sulfide (H2S)-sensitized synergistic therapy of wound bacterial biofilm infection. The rich anion vacancies and Z-scheme heterostructure make the fabricated MoSSe VdW HJ can effectively augment H2S, localized hyperthermia, and reactive oxygen species production under the stimulation of biofilm microenvironments (BME) and irradiation of 808 nm near-infrared (NIR) light. Therefore, MoSSe VdW HJ is capable to integrate H2S gas, chemodynamic, photothermal, and photodynamic therapies to effectively destroy eDNA and polysaccharides in the EPS matrix, thereby breaching the biofilm barrier to eradicate bacteria and facilitate wound healing. The synergistic strategy exhibits superior anti-biofilm and wound repair effects both in vivo and in vitro, thus providing guideline for the development of BME and NIR light activated synergistic therapeutics to fight against refractory biofilm infections.
Persistent Identifierhttp://hdl.handle.net/10722/358419
ISSN
2023 Impact Factor: 12.8
2023 SCImago Journal Rankings: 3.016

 

DC FieldValueLanguage
dc.contributor.authorDong, Jianwen-
dc.contributor.authorZhang, Shuting-
dc.contributor.authorChan, Yau Kei-
dc.contributor.authorLai, Shuangquan-
dc.contributor.authorDeng, Yi-
dc.date.accessioned2025-08-07T00:32:11Z-
dc.date.available2025-08-07T00:32:11Z-
dc.date.issued2025-03-13-
dc.identifier.citationBiomaterials, 2025, v. 320-
dc.identifier.issn0142-9612-
dc.identifier.urihttp://hdl.handle.net/10722/358419-
dc.description.abstractEncapsulated in a self-produced negatively charged extracellular polymeric substance (EPS) matrix, the wound infected bacterial biofilms exhibit formidable resistance to conventional positively charged antibiotics and host's immune responses, which can undoubtedly lead to persistent infections and lethal complications. Nevertheless, developing efficacious strategies to root out stubborn biofilm and promote tissue regeneration still remains a challenge. To resolve this dilemma, a versatile vacancies-rich Z-scheme MoSSe Van der Waals heterojunction (MoSSe VdW HJ) is rationally fabricated as nanoplatform for hydrogen sulfide (H2S)-sensitized synergistic therapy of wound bacterial biofilm infection. The rich anion vacancies and Z-scheme heterostructure make the fabricated MoSSe VdW HJ can effectively augment H2S, localized hyperthermia, and reactive oxygen species production under the stimulation of biofilm microenvironments (BME) and irradiation of 808 nm near-infrared (NIR) light. Therefore, MoSSe VdW HJ is capable to integrate H2S gas, chemodynamic, photothermal, and photodynamic therapies to effectively destroy eDNA and polysaccharides in the EPS matrix, thereby breaching the biofilm barrier to eradicate bacteria and facilitate wound healing. The synergistic strategy exhibits superior anti-biofilm and wound repair effects both in vivo and in vitro, thus providing guideline for the development of BME and NIR light activated synergistic therapeutics to fight against refractory biofilm infections.-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofBiomaterials-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAnion vacancy-
dc.subjectBiofilm infection-
dc.subjectHeterojunction-
dc.subjectSynergistic therapy-
dc.subjectWound repair-
dc.titleVacancies-rich Z-scheme VdW heterojunction as H2S-sensitized synergistic therapeutic nanoplatform against refractory biofilm infections-
dc.typeArticle-
dc.identifier.doi10.1016/j.biomaterials.2025.123258-
dc.identifier.pmid40090255-
dc.identifier.scopuseid_2-s2.0-86000646250-
dc.identifier.volume320-
dc.identifier.eissn1878-5905-
dc.identifier.issnl0142-9612-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats